Clinical efficacy and safety of statins in managing cardiovascular risk.
about
Statins for aortic valve stenosisScreening for hepatocellular carcinoma: patient selection and perspectivesMulti-ethnic analysis of lipid-associated loci: the NHLBI CARe project.Candidate gene association resource (CARe): design, methods, and proof of conceptUse of prescription drug claims data to identify lipid-lowering medication exposure in pharmacoepidemiology studies: potential pitfalls.Clinical and research applications of carotid intima-media thicknessAtorvastatin ameliorates myocardial ischemia/reperfusion injury through attenuation of endoplasmic reticulum stress-induced apoptosis.Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathwayEffects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placentaIntra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne®: Implication for Atherosclerotic Plaque Treatment.Behind-the-counter statins: a silver bullet for reducing costs and increasing access?Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.Safety of statins.National Drug Formulary review of statin therapeutic group using the multiattribute scoring toolRole of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy.Statins for progression of aortic valve stenosis and the best evidence for making decisions in health care.Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword?The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol.Statins for aortic valve stenosis.Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis.Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.Prevalence and Factors Associated With Statin Use Among a Nationally Representative Sample of US Adults: National Health and Nutrition Examination Survey, 2011-2012.Efficacy and safety of the intensive dose of rosuvastatin 40mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2.Effects of Different Types of Statins on Lipid Profile: A Perspective on Asians.Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains.Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers.Atorvastatin protects cardiomyocytes against OGD/R‑induced apoptosis by inhibiting miR‑199a‑5p.Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats.Melatonin synergistically enhances protective effect of atorvastatin against gentamicin-induced nephrotoxicity in rat kidney.Potential drug interactions with statins: Estonian register-based study.The inhibitory effect of simvastatin and aspirin on histamine responsiveness in human vascular endothelial cells.
P2860
Q24203993-DC9BC76C-C683-489B-8850-92E661834471Q30355713-E84C2625-DF8B-4220-B803-6CE4A5156221Q30426816-3A57355F-9119-4AEF-839C-DDFD4F5F9227Q30432077-07A2B282-13FC-4C20-9560-D23983B97F86Q31090652-325BCB53-7879-4E01-A9B8-CAD4B2B5B494Q34978576-9EABF841-26D6-4DF8-9F60-20ECA93C6388Q35016999-29F63F74-8F83-4B3C-A000-C5D1425633A2Q35794521-0363191C-8C37-48C0-8ACC-05752B1F373DQ36024649-0D51CBB8-6B2D-49F1-BD72-783FC3DC72EFQ36145722-5344A612-9F7A-4045-AB89-C99E69E203CBQ36248047-F2B33E67-4A95-4DE0-A2BD-2A14198AC1CAQ36602779-7466D813-6DE6-4339-8961-32002A9A8B73Q37095088-E336C79E-49BA-4DBC-BDC9-195C3438CAF7Q37390983-1CB7714D-3AF4-47A5-B24C-5D9477B186C0Q37474724-A44DE0C6-DFE4-4E8D-8B43-04F29419A68FQ37653029-146A8B10-5CCA-4066-AE53-D1E61D52E647Q37857729-DBDC9245-5AE5-4ED2-B529-5AC6A4BE490DQ37905844-AC1165CE-D436-4D86-88D6-CEE9D305F75FQ38151675-7E3B341E-B9B6-483E-9FF1-027E6A60A1CAQ38946280-8C4BA8EE-C25D-44FF-83C6-8AF4763A4255Q38976172-EE14EBE8-0FC3-4201-BBF0-99B1DD9E1B36Q39158809-1165BE82-F8B9-413E-9B79-73D153A8C077Q39507722-A2AB66BC-141B-475A-855D-0465A199A486Q40434790-B12C0A1E-C7F1-46C1-B539-44B77517293EQ41391827-25A09032-2A8D-4E9D-853D-F4164072B267Q42208366-34DE0ADF-175A-4A87-AFBC-14D79C5C015EQ42603388-FC89D545-F4FD-41E5-9F5F-C1D898636BF2Q42679599-E6B0E87D-9628-4D97-8103-7EF8DC23134CQ43375903-1EAC837D-4A2E-4128-8DD6-D0813F360AEEQ46611381-60E3014D-0F5A-4226-860E-AF5C974A0458Q53732294-1AC74C71-EE92-4747-8F3D-9C27FF83EA30Q54381205-783D67C1-46B7-420C-9E4D-69334DF9E3D4
P2860
Clinical efficacy and safety of statins in managing cardiovascular risk.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Clinical efficacy and safety of statins in managing cardiovascular risk.
@ast
Clinical efficacy and safety of statins in managing cardiovascular risk.
@en
type
label
Clinical efficacy and safety of statins in managing cardiovascular risk.
@ast
Clinical efficacy and safety of statins in managing cardiovascular risk.
@en
prefLabel
Clinical efficacy and safety of statins in managing cardiovascular risk.
@ast
Clinical efficacy and safety of statins in managing cardiovascular risk.
@en
P2860
P921
P356
P1476
Clinical efficacy and safety of statins in managing cardiovascular risk.
@en
P2093
Kiran Musunuru
Navin K Kapur
P2860
P304
P356
10.2147/VHRM.S1653
P407
P577
2008-01-01T00:00:00Z